细胞因子及其受体基因多态性与慢性前列腺炎/慢性盆腔疼痛综合症的关系
|
摘要
第一部分前列腺炎样症状患者转归调查
目的调查“前列腺炎样症状”患者的转归预后及影响临床疗效相关因素，评估当前“慢性前列腺炎”患者的诊疗效果，随访并根据疗效筛选出典型的顽固性慢性前列腺炎患者参与第二部分实验室研究。
方法2004年6月～2004年9月泌尿外科门诊144例“前列腺炎样症状”患者入选，均采用美国国立卫生院慢性前列腺炎症状问卷(NIH-CPSI)调查，取按摩后前列腺液行前列腺液常规检查。患者以按摩后前列腺液白细胞数目为依据，按NIH1995标准分类，接受推荐方案治疗，分别于第6周及1年后接受随访。
结果在规律治疗6周后，总计115例患者继续参与研究。115例前列腺炎样症状患者痊愈率只有13.9％，51.3％患者获得了不同程度的症状缓解或好转，34.8％的患者症状无改善或病情加重。前列腺炎样症状转归与按摩后前列腺液白细胞数目、年龄、有无支原体或衣原体、病程长短等无关。随访1年62例患者继续参与研究，痊愈率只有19.3％，46.7％患者获得了不同程度的症状改善，而33.9％的患者症状无改善或病情加重。ⅢA与ⅢB型前列腺炎样症状患者在治疗过程中疾病类型可以相互转换，由ⅢA型向ⅢB型转换较为多见，由ⅢB型向ⅢA型转换较为少见。
结论采用NIH-CPSI问卷调查结合临床基本检查-前列腺液常规检查、细菌培养，有助于临床前列腺炎的诊断，但前列腺炎样症状其治疗在临床上仍然是一大难题，好转痊愈率较低。以前列腺液白细胞计数为分类基础的前列腺炎样症状各种类型之间在自然病程过程中，存在相互转换，这一结果在对慢性前列腺炎科研数据进行分析时有着重要意义。
第二部分细胞因子及其受体基因多态性与慢性前列腺炎／慢性盆腔疼痛综合症的关系
目的了解细胞因子及其受体基因多态性在慢性前列腺炎／慢性盆腔疼痛综合症组和正常对照组中的分布，探讨其在慢性前列腺炎发病中的作用及其在诊断及治疗中的意义。
方法正常对照组51人，从第一部分研究中筛选出典型CP／CPPS患者24人，均为湖南汉族。采用TBG公司DNA10分钟快速提取试剂盒提取DNA，使用美国PEL-FREEZ公司的细胞因子基因型检测试剂盒，采用序列特异性引物聚合酶链反应方法(SSP-PCR)检测受试者13种细胞因子和细胞因子受体22个位点的基因型：IL-1α-889C／T、IL-1β(-511C／T、+3962C／T)、IL-1RPstⅠ970 C／T、IL-1Ra mspⅠ11100C／T、IL-4Rα+1902A／G、IL-12-1188A／C、IFN-γUTR5644A／T、TGF-β1(密码子10C／T、密码子25C／G)、TNF-α(-308A／G、-238A／G)、IL-2(-330T／G、+166G／T)、IL-4(-1098G／T、-590C／T、-33C／T)、IL-6(-174C／G、nt565A／G)、IL-10(-1082A／G、-819C／T、-592A／C)；采用双抗体夹心ELISA法，检测51例正常对照者外周血IL-10含量，同时检测20例CP／CPPS患者按摩后前列腺液IL-10含量。
结果
1．汉族人群在IL-10-1082位点，G等位基因频率(在患者人群2.1％，在正常对照组4.9％)，明显低于A等位基因频率(在患者人群97.9％，在正常对照组95.1％)且该位点基因型在两组间分布无显著性差别。
2．和对照组比较，患者组在IL-10(-819C／T)位点T／T基因型(62.5％vs 31.3％)更为多见，差别有显著性意义(P＜0.05)；在IL-10(-592C／A)位点A／A基因型(62.5％vs 31.3％)更为多见，差别有显著性意义(P＜0.05)。
3．与对照组比较，患者组在-819位点T等位基因频率(75.0％vs55.9％)更为多见，差别有显著性意义(P＜0.05)；在-592位点A等位基因(75.0％vs 55.9％)更为多见，差别有显著性意义(P＜0.05)。
4．IL-10(-1082，-819，-592)ATA／ATA基因型在CP／CPPS组较之正常组更为多见(62.5％vs 31.2％，P＜0.05)，差别有统计学意义，与CP／CPPS发病有关。
5．IL-10(-1082，-819，-592)的基因型分布，与CP／CPPS患者的年龄、病程、CP／CPPS类型(ⅢA／ⅢB)、CPSI-NIH症状问卷中疼痛项目评分、疼痛程度、射精后痛、排尿症状、排尿痛、客观症状、生活质量影响等各项评分以及总分等均没有显著关系。
6．正常对照人群IL-10 ACC／ACC组、GCC／ATA+GCC／ACC组与ATA／ATA组比较，外周血IL-10产量均有明显差别(分别为256.8±209.7 pg／ml，355.2±298.4 pg／ml，110.7±102.6 pg／ml)差别有显著性意义；ATA／ACC组与ATA／ATA组比较，IL-10产量虽有增加(分别为205.1±196.0 pg／m，110.7±102.6 pg／m)但差别无显著性意义(P)0.05)。
7．CP／CPPS患者IL-10基因型多态性与前列腺液IL-10浓度无明显关系。
8．IL-4-590 T／C位点两组间基因型频率存在组间差别，与对照组比较，患者组T／C杂合子基因型更为多见(50.0％vs 27.5％)，但统计分析其P值临近显著性水平(P=0.056)，差别无统计学显著性意义。
9．其他位点基因型频率在两组间没有显著性差异。
10．TGFβ(Codon10，25)及TNFα(-308，-238)单倍体型、基因型在两组间频率分布无显著性差异，与CP／CPPS发病关系不大。
结论汉族人群抗炎细胞因子基因型多态性与CP／CPPS发病有关，促炎细胞因子及其受体基因多态性与CP／CPPS发病关系不大。IL-10基因多态性决定外周血IL-10产量，CP／CPPS患者中IL-10低产量基因型频率多见。汉族人群中IL-10-1082位点G等位基因频率明显低于白种高加索人。汉族人群IL-10基因与CP／CPPS发病的关系不是表现在IL-10-1082位点基因多态性，而是表现在与IL-10-1082位点相连锁的-819，-592位点基因多态性。IL-10基因多态性并不能直接决定患者前列腺液IL-10含量。分析患者细胞因子基因型多态性有助于采取以人为本的个性化治疗。
PART 1 Follow up of patients with "prostatitis-like symptom"
Objective To study the clinical curative effect and prognosis of "prostatitis-like symptom" and the relevant factors affecting the curative results. To select the typical stubbornness chronic prostatitis patient to participate in the second part of laboratory research according to curative effect.
Methods 144 cases of "prostatitis-like symptom" patients in our hospital were adopted from June, 2004 to September, 2004. All the patients received the investigation based on NIH-CPSI questionnaire. Expressed prostatic fluids(EPS) were acquired and prostatic fluid routine inspection were executed. Patients were classified based on white blood cell count in EPS according to the NIH1995 standard classification, and accepts the recommendated treatment. Patients received follow-up visit after 6 weeks and 1 year respectively.
Results After 6 week regular treatment, 115 patients continued to participate in the research. Convalescing rate of the 115 "prostatitis-like symptom" patients was only 13.9%. 51.3% patients obtained the varying degree of alleviation of symptoms or the condition changed for the better.34.8% patients' symptoms did not have a improvement or the condition aggravated. Curative effect of "prostatitis-like symptom" had nothing to do with the age, the course of illness, neither with whether there was the mycoplasma or the chlamydia as well as white blood cell number in EPS.ⅢA Type andⅢB Type "prostatitis-like symptom" may had the interconversion during patient's course of treatment. Situation was common byⅢA change to theⅢB, and less wasⅢB to theⅢA.
Conclusions Combining the NIH-CPSI questionnaire survey with clinical basic inspections-prostate gland fluid routine inspection and the bacilli culture help to make a clinical diagnosis of prostatitis. "prostatitis-like symptom" was still a difficult problem in clinical aspect, with the amelioration rate and convalescing rate was low. Interconversion existed between two types of "prostatitis-like symptom" during the course of disease, which was meaningful in the case of analyzing scientific research data about chronic prostatitis.
PART 2 Association of gene polymorphisms of cytokine and cytokine receptor with chronic prostatitis/chronic pelvic pain syndrome
Objective: To research the distribution of gene polymorphisms of cytokines and cytokine receptors in CP/CPPS patients group and health control group. To explore the role of gene polymorphism of cytokine and cytokine receptor in CP/CPPS and their role in diagnosis and treatment of CP/CPPS.
Methods: We have genotyped 24 patients diagnosed with typical CP/CPPS which selected from research of part one and 51 health controls from the Han nationality population in Hunan province for the single nucleotide polymorphisms of 13 cytokines at 22 site: IL-lα-889 C/T、IL-1β(-511 C/T、＋3962C/T)、IL-1RPst 1970 C/T, IL-1Ra mspⅠ11100 C/T、IL-4Rα＋1902 A/G、IL-12-1188 A/C、IFN-γUTR5644 A/T、TGF-β1 (codon10 C/T、codon25 C/G)、TNF-α(-308 A/G、-238 A/G)、IL-2 (-330 T/G、＋166G/T)、IL-4 (-1098 G/T、-590 C/T、-33C/T)、IL-6 (-174 C/ G、nt565 A/G)、IL-10 (-1082 A/ G、-819C/T、-592 A/C). Clinical data were collected on all patients. DNA was extracted with BioGene-Expuze 10 DNA kit supplied by Texas BioGene Incorporation. Genotyping was carried out using SSP-PCR technique with cytokine genetyping kit supplied by PEL-FREEZ Incorporation. IL-10 level in peripheral blood of 51 health controls and in EPS of 20
CP/CPPS patients were tested using ELISA technique.
Results:
1.The frequency of G allele (2.1% in patients group, 4.9% in health control group) of IL-10 at -1082 was lower than that of A allele(97.9% in patients group, 95.1% in health control group) obviously in Han nationality population. There were no significant difference of allele frequencies between patients group and health control group.
2.A statistically significant difference was observed in the genetype frequency of the polymorphisms between the group of patients and the group of healthy individuals with the polymorphism of the IL-10 at -1082,where frequency of T/T genetype was higher in patient group(62.5% vs 31.3%,p＜0.05). A statistically significant difference was observed in the genetype frequency of the polymorphisms between the group of patients and the group of healthy individuals with the polymorphism of the IL-10 at -592, where frequency of A/A genetype was higher in patient group(62.5% vs 31.3%,p＜0.05).
3.A statistically significant difference was observed in the allele frequency of the polymorphisms between the group of patients and the group of healthy individuals with the polymorphism of the IL-10 at -819, where frequency of T allele was higher in patient group(75.0% vs 55.9%,p＜0.05). A statistically significant difference was observed in the allele frequency of the polymorphisms between the group of patients and the group of healthy individuals with the polymorphism of the IL-10 at -592, where frequency of A allele was higher in patient group(75.0% vs 55.9%,p＜0.05).
4.A statistically significant difference was observed in the genetype frequency of the polymorphisms between the group of patients and the group of healthy individuals with the polymorphism of the IL-10 at -1082,-819,-592, where frequency of ATA/ATA genetype was higher in patient group (62.5% vs 31.2%,P＜0.05 )
5.There were no statistically significant association of distribution of genetype frequency with age, course, CP/CPPStype (ⅢA/ⅢB) and neither with score of pain, pain degree, pain after ejaculation, symptom with void, pain during void, objective symptom, quality of life according to NIH-CPSI questionnaire.
6.The IL-10 level in peripheral blood of ACC/ACC group and GCC/ATA＋GCC/ACC group were statistically significantly different from that of ATA/ATA group(256.8±209.7 pg/ml, 355.2±298.4 pg/ml, 110.7±102.6 pg/ml,respectively). Level of IL-10 in ATA/ACC group was higher than that in ATA/ATA group, however the difference was not significant.
7.Gene polymorphism at -1082,-819,-592 of IL-10 have no statistically significant association with levels of IL-10 in EPS of CP/CPPS patients.
8. Genetype T/C of IL-4 at -590 was found more frequently in the patients (50.0% vs 27.5%), while the difference was not statistically significant,with P value was 0.056 that was cloes to the critical value.
9. There was no statistically significant difference observed between healthy group and patients group on other researched gene polymorphisms.
10. No statistically significant difference was observed in the haplotype frequency and genetype frequency of TGFβgene (codon 10, condon 25) and TNFαgene (-308, -238) between the CP/CPPS patients and the healthy control group.
Conclusions: Our data suggested that anti-inflammation cytokine gene polymorphisms but not proinflammation cytokine gene polymorphisms were associated with the pathogenesis of CP/CPPS. IL-10 gene polymorphism prearranged the level of IL-10 in peripheral blood. Low product genetype of IL-10 was more frequently obserbed in CP/CPPS population. Frequency of allele G of IL-10 at -1082 was significantly lower in Han nationality population than that in Caucasians. Gene polymorphisms of IL-10 at -1082 cann't establish its role in pathogenesis of CP/CPPS, however gene polymorphisms of IL- 10 at -819 and at -592, which were linkage with site -1082, can play its role in etiology of CP/CPPS. Gene polymorphism of IL-10 cann't prearrange the level of IL-10 in EPS of CP/CPPS patients. Analysis of gene polyphisms of cytokine help the patient to accepte a individual treatment in consideration of humanity.
目的调查“前列腺炎样症状”患者的转归预后及影响临床疗效相关因素，评估当前“慢性前列腺炎”患者的诊疗效果，随访并根据疗效筛选出典型的顽固性慢性前列腺炎患者参与第二部分实验室研究。
方法2004年6月～2004年9月泌尿外科门诊144例“前列腺炎样症状”患者入选，均采用美国国立卫生院慢性前列腺炎症状问卷(NIH-CPSI)调查，取按摩后前列腺液行前列腺液常规检查。患者以按摩后前列腺液白细胞数目为依据，按NIH1995标准分类，接受推荐方案治疗，分别于第6周及1年后接受随访。
结果在规律治疗6周后，总计115例患者继续参与研究。115例前列腺炎样症状患者痊愈率只有13.9％，51.3％患者获得了不同程度的症状缓解或好转，34.8％的患者症状无改善或病情加重。前列腺炎样症状转归与按摩后前列腺液白细胞数目、年龄、有无支原体或衣原体、病程长短等无关。随访1年62例患者继续参与研究，痊愈率只有19.3％，46.7％患者获得了不同程度的症状改善，而33.9％的患者症状无改善或病情加重。ⅢA与ⅢB型前列腺炎样症状患者在治疗过程中疾病类型可以相互转换，由ⅢA型向ⅢB型转换较为多见，由ⅢB型向ⅢA型转换较为少见。
结论采用NIH-CPSI问卷调查结合临床基本检查-前列腺液常规检查、细菌培养，有助于临床前列腺炎的诊断，但前列腺炎样症状其治疗在临床上仍然是一大难题，好转痊愈率较低。以前列腺液白细胞计数为分类基础的前列腺炎样症状各种类型之间在自然病程过程中，存在相互转换，这一结果在对慢性前列腺炎科研数据进行分析时有着重要意义。
第二部分细胞因子及其受体基因多态性与慢性前列腺炎／慢性盆腔疼痛综合症的关系
目的了解细胞因子及其受体基因多态性在慢性前列腺炎／慢性盆腔疼痛综合症组和正常对照组中的分布，探讨其在慢性前列腺炎发病中的作用及其在诊断及治疗中的意义。
方法正常对照组51人，从第一部分研究中筛选出典型CP／CPPS患者24人，均为湖南汉族。采用TBG公司DNA10分钟快速提取试剂盒提取DNA，使用美国PEL-FREEZ公司的细胞因子基因型检测试剂盒，采用序列特异性引物聚合酶链反应方法(SSP-PCR)检测受试者13种细胞因子和细胞因子受体22个位点的基因型：IL-1α-889C／T、IL-1β(-511C／T、+3962C／T)、IL-1RPstⅠ970 C／T、IL-1Ra mspⅠ11100C／T、IL-4Rα+1902A／G、IL-12-1188A／C、IFN-γUTR5644A／T、TGF-β1(密码子10C／T、密码子25C／G)、TNF-α(-308A／G、-238A／G)、IL-2(-330T／G、+166G／T)、IL-4(-1098G／T、-590C／T、-33C／T)、IL-6(-174C／G、nt565A／G)、IL-10(-1082A／G、-819C／T、-592A／C)；采用双抗体夹心ELISA法，检测51例正常对照者外周血IL-10含量，同时检测20例CP／CPPS患者按摩后前列腺液IL-10含量。
结果
1．汉族人群在IL-10-1082位点，G等位基因频率(在患者人群2.1％，在正常对照组4.9％)，明显低于A等位基因频率(在患者人群97.9％，在正常对照组95.1％)且该位点基因型在两组间分布无显著性差别。
2．和对照组比较，患者组在IL-10(-819C／T)位点T／T基因型(62.5％vs 31.3％)更为多见，差别有显著性意义(P＜0.05)；在IL-10(-592C／A)位点A／A基因型(62.5％vs 31.3％)更为多见，差别有显著性意义(P＜0.05)。
3．与对照组比较，患者组在-819位点T等位基因频率(75.0％vs55.9％)更为多见，差别有显著性意义(P＜0.05)；在-592位点A等位基因(75.0％vs 55.9％)更为多见，差别有显著性意义(P＜0.05)。
4．IL-10(-1082，-819，-592)ATA／ATA基因型在CP／CPPS组较之正常组更为多见(62.5％vs 31.2％，P＜0.05)，差别有统计学意义，与CP／CPPS发病有关。
5．IL-10(-1082，-819，-592)的基因型分布，与CP／CPPS患者的年龄、病程、CP／CPPS类型(ⅢA／ⅢB)、CPSI-NIH症状问卷中疼痛项目评分、疼痛程度、射精后痛、排尿症状、排尿痛、客观症状、生活质量影响等各项评分以及总分等均没有显著关系。
6．正常对照人群IL-10 ACC／ACC组、GCC／ATA+GCC／ACC组与ATA／ATA组比较，外周血IL-10产量均有明显差别(分别为256.8±209.7 pg／ml，355.2±298.4 pg／ml，110.7±102.6 pg／ml)差别有显著性意义；ATA／ACC组与ATA／ATA组比较，IL-10产量虽有增加(分别为205.1±196.0 pg／m，110.7±102.6 pg／m)但差别无显著性意义(P)0.05)。
7．CP／CPPS患者IL-10基因型多态性与前列腺液IL-10浓度无明显关系。
8．IL-4-590 T／C位点两组间基因型频率存在组间差别，与对照组比较，患者组T／C杂合子基因型更为多见(50.0％vs 27.5％)，但统计分析其P值临近显著性水平(P=0.056)，差别无统计学显著性意义。
9．其他位点基因型频率在两组间没有显著性差异。
10．TGFβ(Codon10，25)及TNFα(-308，-238)单倍体型、基因型在两组间频率分布无显著性差异，与CP／CPPS发病关系不大。
结论汉族人群抗炎细胞因子基因型多态性与CP／CPPS发病有关，促炎细胞因子及其受体基因多态性与CP／CPPS发病关系不大。IL-10基因多态性决定外周血IL-10产量，CP／CPPS患者中IL-10低产量基因型频率多见。汉族人群中IL-10-1082位点G等位基因频率明显低于白种高加索人。汉族人群IL-10基因与CP／CPPS发病的关系不是表现在IL-10-1082位点基因多态性，而是表现在与IL-10-1082位点相连锁的-819，-592位点基因多态性。IL-10基因多态性并不能直接决定患者前列腺液IL-10含量。分析患者细胞因子基因型多态性有助于采取以人为本的个性化治疗。
PART 1 Follow up of patients with "prostatitis-like symptom"
Objective To study the clinical curative effect and prognosis of "prostatitis-like symptom" and the relevant factors affecting the curative results. To select the typical stubbornness chronic prostatitis patient to participate in the second part of laboratory research according to curative effect.
Methods 144 cases of "prostatitis-like symptom" patients in our hospital were adopted from June, 2004 to September, 2004. All the patients received the investigation based on NIH-CPSI questionnaire. Expressed prostatic fluids(EPS) were acquired and prostatic fluid routine inspection were executed. Patients were classified based on white blood cell count in EPS according to the NIH1995 standard classification, and accepts the recommendated treatment. Patients received follow-up visit after 6 weeks and 1 year respectively.
Results After 6 week regular treatment, 115 patients continued to participate in the research. Convalescing rate of the 115 "prostatitis-like symptom" patients was only 13.9%. 51.3% patients obtained the varying degree of alleviation of symptoms or the condition changed for the better.34.8% patients' symptoms did not have a improvement or the condition aggravated. Curative effect of "prostatitis-like symptom" had nothing to do with the age, the course of illness, neither with whether there was the mycoplasma or the chlamydia as well as white blood cell number in EPS.ⅢA Type andⅢB Type "prostatitis-like symptom" may had the interconversion during patient's course of treatment. Situation was common byⅢA change to theⅢB, and less wasⅢB to theⅢA.
Conclusions Combining the NIH-CPSI questionnaire survey with clinical basic inspections-prostate gland fluid routine inspection and the bacilli culture help to make a clinical diagnosis of prostatitis. "prostatitis-like symptom" was still a difficult problem in clinical aspect, with the amelioration rate and convalescing rate was low. Interconversion existed between two types of "prostatitis-like symptom" during the course of disease, which was meaningful in the case of analyzing scientific research data about chronic prostatitis.
PART 2 Association of gene polymorphisms of cytokine and cytokine receptor with chronic prostatitis/chronic pelvic pain syndrome
Objective: To research the distribution of gene polymorphisms of cytokines and cytokine receptors in CP/CPPS patients group and health control group. To explore the role of gene polymorphism of cytokine and cytokine receptor in CP/CPPS and their role in diagnosis and treatment of CP/CPPS.
Methods: We have genotyped 24 patients diagnosed with typical CP/CPPS which selected from research of part one and 51 health controls from the Han nationality population in Hunan province for the single nucleotide polymorphisms of 13 cytokines at 22 site: IL-lα-889 C/T、IL-1β(-511 C/T、＋3962C/T)、IL-1RPst 1970 C/T, IL-1Ra mspⅠ11100 C/T、IL-4Rα＋1902 A/G、IL-12-1188 A/C、IFN-γUTR5644 A/T、TGF-β1 (codon10 C/T、codon25 C/G)、TNF-α(-308 A/G、-238 A/G)、IL-2 (-330 T/G、＋166G/T)、IL-4 (-1098 G/T、-590 C/T、-33C/T)、IL-6 (-174 C/ G、nt565 A/G)、IL-10 (-1082 A/ G、-819C/T、-592 A/C). Clinical data were collected on all patients. DNA was extracted with BioGene-Expuze 10 DNA kit supplied by Texas BioGene Incorporation. Genotyping was carried out using SSP-PCR technique with cytokine genetyping kit supplied by PEL-FREEZ Incorporation. IL-10 level in peripheral blood of 51 health controls and in EPS of 20
CP/CPPS patients were tested using ELISA technique.
Results:
1.The frequency of G allele (2.1% in patients group, 4.9% in health control group) of IL-10 at -1082 was lower than that of A allele(97.9% in patients group, 95.1% in health control group) obviously in Han nationality population. There were no significant difference of allele frequencies between patients group and health control group.
2.A statistically significant difference was observed in the genetype frequency of the polymorphisms between the group of patients and the group of healthy individuals with the polymorphism of the IL-10 at -1082,where frequency of T/T genetype was higher in patient group(62.5% vs 31.3%,p＜0.05). A statistically significant difference was observed in the genetype frequency of the polymorphisms between the group of patients and the group of healthy individuals with the polymorphism of the IL-10 at -592, where frequency of A/A genetype was higher in patient group(62.5% vs 31.3%,p＜0.05).
3.A statistically significant difference was observed in the allele frequency of the polymorphisms between the group of patients and the group of healthy individuals with the polymorphism of the IL-10 at -819, where frequency of T allele was higher in patient group(75.0% vs 55.9%,p＜0.05). A statistically significant difference was observed in the allele frequency of the polymorphisms between the group of patients and the group of healthy individuals with the polymorphism of the IL-10 at -592, where frequency of A allele was higher in patient group(75.0% vs 55.9%,p＜0.05).
4.A statistically significant difference was observed in the genetype frequency of the polymorphisms between the group of patients and the group of healthy individuals with the polymorphism of the IL-10 at -1082,-819,-592, where frequency of ATA/ATA genetype was higher in patient group (62.5% vs 31.2%,P＜0.05 )
5.There were no statistically significant association of distribution of genetype frequency with age, course, CP/CPPStype (ⅢA/ⅢB) and neither with score of pain, pain degree, pain after ejaculation, symptom with void, pain during void, objective symptom, quality of life according to NIH-CPSI questionnaire.
6.The IL-10 level in peripheral blood of ACC/ACC group and GCC/ATA＋GCC/ACC group were statistically significantly different from that of ATA/ATA group(256.8±209.7 pg/ml, 355.2±298.4 pg/ml, 110.7±102.6 pg/ml,respectively). Level of IL-10 in ATA/ACC group was higher than that in ATA/ATA group, however the difference was not significant.
7.Gene polymorphism at -1082,-819,-592 of IL-10 have no statistically significant association with levels of IL-10 in EPS of CP/CPPS patients.
8. Genetype T/C of IL-4 at -590 was found more frequently in the patients (50.0% vs 27.5%), while the difference was not statistically significant,with P value was 0.056 that was cloes to the critical value.
9. There was no statistically significant difference observed between healthy group and patients group on other researched gene polymorphisms.
10. No statistically significant difference was observed in the haplotype frequency and genetype frequency of TGFβgene (codon 10, condon 25) and TNFαgene (-308, -238) between the CP/CPPS patients and the healthy control group.
Conclusions: Our data suggested that anti-inflammation cytokine gene polymorphisms but not proinflammation cytokine gene polymorphisms were associated with the pathogenesis of CP/CPPS. IL-10 gene polymorphism prearranged the level of IL-10 in peripheral blood. Low product genetype of IL-10 was more frequently obserbed in CP/CPPS population. Frequency of allele G of IL-10 at -1082 was significantly lower in Han nationality population than that in Caucasians. Gene polymorphisms of IL-10 at -1082 cann't establish its role in pathogenesis of CP/CPPS, however gene polymorphisms of IL- 10 at -819 and at -592, which were linkage with site -1082, can play its role in etiology of CP/CPPS. Gene polymorphism of IL-10 cann't prearrange the level of IL-10 in EPS of CP/CPPS patients. Analysis of gene polyphisms of cytokine help the patient to accepte a individual treatment in consideration of humanity.
引文
[1] Krieger JN,Nyberg LJ,Nickel JC.NIH consensus definition and classification of prostatitis. JAMA,1999 ,282 (3): 236-237
[2] Litwin MS,McNaughton-Collins M,Fowler FJ,et al.The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure.Chronic Prostatitis Collaborative Research Network.J Urol, 1999, 162(2):369-375
[3]Nickel JC,Downey J,Hunter D, et al.Prevalence of prostatitis-like symptoms in a population based study using the national institutes of health chronic prostatitis symptom index. J Urol, 2001,165(3): 842-845
[4] Hoffmann SC, Stanley EM, Cox ED, et al. Ethnicity greatly influences cytokine gene polymorphism distribution. American Journal of Transplantation. 2002, 2(6):560-567
[5] Miller LJ, Fischer KA, Goralnick SJ, Litt M, Burleson JA,Albertsen P, Kreutzer DL.Interleukin-10 levels in seminal plasma: implications for chronic prostatitis-chronic pelvic pain syndrome. J Urol , 2002, 167 (2 Pt 1)::753—756
[6] Hochreiter WW, Nadler RB, Koch AE,et al. Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions. Urology. 2000 ,56 (6): 1025-1029
[7]Krieger JN, Riley DE,Cheah PY, et al.Epidemiology of prostatitis: new evidence for a world-wide problem. World J Urol,2003,21(2): 70-74
[8] Ludwig M,Schroeder-Printzen I,Ludecke G,et al. Comparison of expressed prostatic secretions with urine after prostatic massage-a means to diagnose chronic prostatitis/inflammatory chronic pelvic pain syndrome. Urology ,2000, 55: 175-177
[9] Lobel B, Rodriguez A.Chronic prostatitis: what we know, what we do not know,and what we should do! World J Urol, 2003, 21 (2) : 57-63
[10] Cheah PY,Liong LM,Yuen KH,et al.Chronic prostatitis: Symptom survey with follow-up clinical evaluation.Urology, 2003, 61(1): 60-64
[11] Nickel JC, Downey JA, Nickel KR, Prostatitis-like symptoms: one year later. BJU Int. 2002 , 90(7): 678-681
[12] Roberts RO,Lieber MM,Rhodes T,etal.Prevalence of a physician- assigned diagnosis of prostatitis: the Olmsted county study of urinary symptoms and health status among men.Urology, 1998,51 (4) :578-584
[13] Harris MT, Feldberg RS, Lau KM,et al. Expression of proinflammatory genes during estrogen-induced inflammation of the rat prostate. Prostate, 2000, 44(1): 19-25
[14] Naber KG,Weidner W.Chronic prostatitis-an infectious disease? Journal of Antimicrobial Chemtherapy, 2000,46 (2):157-161
[15] Mandar R, Raukas E,Turk S,et al. Mycoplasmas in semen of chronic prostatitis patients. Scand J Urol Nephrol, 2005,39(6): 479-482
[16] Abdelatif OM,Chandler FW, McGuire JrBS. Chlamydia trachomatis in chronic abacterial prostatitis: demonstration by colorimetric in situ hybridization. Hum Pathol, 1991,22(1):41-44
[17] 曹伟，刘礼，童明华。淋球菌、支原体和沙眼衣原体在慢性前列腺炎中的感染分布及耐药性分析。湖南医科大学学报，2003，28(2)：177-179
[18] 蒋朝晖，杨金瑞．前列腺液白细胞计数在慢性前列腺炎诊断中的作用。中华泌尿外科杂志，2002，23(1)：32-34
[19] Schaeffer AJ,Knauss JS,Landis R, et al.Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis:the national institutes of health chronic prostatitis cohort study.J Urol,2002,168 (3):1048-1053
[20] Nickel JC,Downey J,Johnston B,et al.Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronie pelvic pain syndrome:a prospective multicenter clinical trial.J Urol,2001,165 (5):1539-1544
[21] Batstone GR, Doble A, Batstone D. Chronic prostatitis. Curr Opin Urol, 2003, 13(1):23-29
[22] Karlovsky ME,Pontari MA:Theories of prostatitis etiology.Curr Urol Rep.2002,3(4):307-312
[23] Jang TL,Schaeffer AJ.The role of cytokines in prostatitis.World J Urol,2003, 21 (1): 95-99
[24] Riley DE, Krieger JN. X Chromosomal short tandem repeat polymorphisms near the phosphorglycerate kinase gene in men with chronic prostatitis. Biochim Biophys Acta,2002,1586(1):99-107
[25] Shoskes DA, Albakri Q, Thomas K,et al.Cytokine polymorphisms in men withchronic prostatitis/chronic pelvic pain syndrome: association with diagnosis and treatment response. J Urol,2002,168(1):331-5
[26] SNP的原理和临床应用。朱平。临床分子遗传学。北京，北京医科大学出版社，2002年4月第一版：65-71
[27] 郭义峰 谭建明 李荣宇，等。寡核苷酸芯片在细胞因子及其受体单核苷酸多态性检测中的应用。中华医学杂志，2005，85(25)：1757-1761
[28] Orhan I, Onur R, Ilhan N,et al. Seminal plasma cytokine levels in the diagnosis of chronic pelvic pain syndrome. Int J Urol,2001,8(9):495-9
[29] 杨进益，叶林，姜洪波，等。 慢性前列腺炎患者前列腺液IL-1B和TNF-A的检测及意义．中华男科学杂志，2004，10(6)：449-454
[30] 段志国，杨为民。慢性前列腺炎患者前列腺液中IL-2、IL-8及IL-10水平分析．中华男科学，2005，11(3)：201-203
[31] Lin MY, Albertson TE. Genomic polymorphisms in sepsis. Crit Care Med, 2004, 32 (2):569-579
[32] Louis E, Franchimont D, Piron A, et al:Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans.Clin Exp Immunol,1998, 113 (3):401-406
[33] Mira JP, Cariou A,Grall F, et al. Association of TNF2a, TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA,1999,282 (6): 561-568
[34] Mullighan C,Heatley S,Doherty K,et al.Non-HLA immunogenetic polymorphisms and the risk of complications after allogenetic hemopoietic stem cell transplantation. Transplantion, 2004, 27(4):587-596
[35] Lee H, Clark B, Gooi HC,et al. Influence of recipient and donor IL-lalpha, IL-4, and TNF alpha genotypes on the incidence of acute renal allograft rejection. J Clin Pathol. 2004,57(1): 101-103
[36] Macones G,Parry S,Elkousy, etal.A polymorphism in the promoter region of TNF and bacterial vaginesis:preliminary evidence of gene environment interaction in the etiology of spontaneous preterm birth.Am J Obestect Gynecol, 2004, 160 (6): 1504-1508
[37] Krieger JN, Riley DE, Cheah PK, et al.Epidemiology of prostatitis: new evidence for a world-wide problem.World J Urol,2003,21 (2): 70-74
[38] Naber KG;Weidner W.Chronic prostatitis-an infectious disease? .Journal of Antimicrobial Chemtherapy, 2000, 46 (2):157-161
[39] Motrich RD, Maccioni M,Molina R, et al. Presence of INFgamma-secreting lymphocytes specific to prostate antigens in a group of chronic prostatitis patients. Clin Immunol, 2005, 116(2): 149-57
[40] 羊继平，齐隽，闵志廉，等。肾移植受者细胞因子基因多态性与术后发生感染的关系。中华器官移植杂志，2005，26(2)：97-99
[41] 江，马文波，章锦才，等。IL-6基因多态性与汉族人群慢性牙周炎敏感性关系的研究．广东牙病防治。2003,11(2)：89-92
[42] Fishman D,Faulds G.Jeffery R,et al.The effect of novel polymorphisms in the interleukin-6(IL-6)gene on IL-6 transcription and plasma IL-6 levels,and an association with systemic-onset juvenile chronic arthritis,J Clin Invest, 1998,102(7):1369-1376
[43] Jones KG, Brull DJ, Brown LC, et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation,2001, 103 (18):2260-2265
[44] Rousser F, Carcia E,Defrance T, et al.Interleukin-10 is a potent growth and differentiation factor for activated human B lymphocytes.Proc Natl Acad Sci USA,1992,89 (5) :1890-1893
[45] Eskdale J, Kube D, Tesch H,et al. Mapping of the human IL10 gene and further characterization of the 5_ flanking sequence. Immunogenetics, 1997,46 (2):120-128
[46] Hoffmann SC,Stanley EM,Cox ED,et al.Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28 stimulated peripheral blood lymphocytes.Transplantation, 2001,72 (8): 1444-1450
[47] 王娟，刘岩雪，倪虹，等。白细胞介素-10启动子-872位点多态性在中国汉 族人群高频率发生。南开大学学报(自然科学版)，2004，37(3)：80-82
[48] Turner DM, Williams DM, Sankaran D, et al. An investigation of polymorphism in the interleukin -10 gene promoter. Eur J Immunogenet,1997, 24 (1):1-8
[49] Lin MY, Storer B, Martin PJ et al. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation.N Engl J Med, 2003,349(23):2201-10
[50] Mok CC,Lanchbury JS,Chan DW, et al. Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum, 1998, 41(6):1090-1095
[51] Crawley E,Kay R, Silliboume J, et al. Polymorphic haplotypes of the interleukin- 10 5' flanking region determine variable interleukin- 10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. ArthritisRheum,1999, 42(6): 1101-1108
[52] 张嘉琳，陈虹，胡良平，等。细胞介素4和10基因多态性与儿童哮喘的相关性及对细胞因子表达的影响。中华医学杂志，2002，82(2)：114-118
[53] Pongtari MA,Ruggieri MR.Mechanisms in prostatitis/chronic pelvic pain syndrome. J Urol. 2004, 172(3):839-845
[54] Hochreiter WW, Nadler RB, Koch AE,et al. Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions. Urology. 2000,56(6): 1025-1029
[55] Sugiyama E, Kuroda A, Taki H, et al. Interleukin 10 cooperates with interleukin 4 to suppress inflammatory cytokine production by freshly prepared adherent rheumatoid synovial cells. J Rheumatol,1995,22 (11): 2020-6
[56] Bijlsma FJ,vanKuik J, Tilanus MG;et al.Donor interleukin-4 promoter gene polymorphism influences allograft rejection after heart transplantation. Journal of Heart & Lung Transplantation, 2002, 21(3):340-6
[57] Maccioni M,Rivero VE,Riera CM.prostaein(or rat prostatic steroid binding protein) is a major autoantigen in experimental autoimmune prostatitis.Clinical Experimental Immunology, 1998,112(2): 159-165
[58] Seethalakshmi L,Bala RS,Malhotra RK,et al. 17 beta-Estradiol Induced Prostatitis in the Rat is an Autoimmune Disease.The Journal of Urology,1996, 156 (5):1838-1842
[59] 蒋玲，龚莹，江维岩，等。白细胞介素1α、4、6、TNF基因多态性与桥本甲状腺炎的关系。中华内分泌代谢杂志，2004，20(6)：528-530
[60] Hershey GK, Friedrich MF, Esswein LA,et al.The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor .N Engl J Med, 1997,337(24): 1720
[61] 羊继平，齐隽，闵志廉，等。细胞因子基因多态性对肾移植急性排斥的影响。肾脏病与透析肾移植杂志，2005，14(1)：28-33
[62] Krieger JN , Riley DE. Chronic prostatitis: charlottesville to Seattle. J Urol,2004, 172(6 Pt 2): 2557-2560
[63] Nickel JC, Downey J, Ardern D,et al. Failure of a monotherapy strategy for difficult chronic prostatitis/chronic pelvic pain syndrome. J Urol. 2004,172(2):551-4
[64] Charles P, Elliott M J, Davis D .Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis. J Immunol, 1999, 163(3): 1521-1528; Vastag B. Prostate disease begs understanding. JAMA, 2001, 286(4):406-408
[65] Jiang Y, McCabe D, Aitchison R,et al. Relationship of Genant scoring method with Larsen scoring method in randomized, double- blind, placebo controlled trial of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Arthritis Rheum 1998,41(Suppl):S50
[66] Woods JM, Katschke KJ,Volin MV.IL-4 Adenoviral Gene Therapy Reduces Inflammation,Proinflammatory Cytokines, Vascularization, and Bony Destruction in Rat Adjuvant-Induced Arthritis. The Journal of Immunology,2001,166(2): 1214-1222
[67] Maini RN, Breedveld FC, Kalden JR, et al. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate.Arthritis Rheum.2004,50(4): 1051-65
[1] Krieger JN, Riley DE,Cheah PY, et al.Epidemiology of prostatitis: new evidence for a world-wide problem.World J Urol,2003,21(2): 70-74
[2] Nickel JC,Downey J,Hunter D,et al.Prevalence of prostatitis-like symptoms in a population based study using the National institude of Health chronic prostatitis symptom index.J Urol,2001,165(3):842-845
[3 ]Batstone GR, Doble A, Batstone D. Chronic prostatitis. Curr Opin Urol, 2003, 13(1):23-9
[4] Moon TD, Hagen L, Heisey DM .Urinary symptomatology in younger men. Urology, 1997, 50(5):700-703
[4] John H,Barghorn A,Funke GNoinflammatory chronic pelvic pain synd-rome:immunological study in blood,ejaculate and prostate tissue.Eur Urol,2001,39(1):72-78
[6] Pongtari MA,Ruggieri MR.Mechanisms in prostatitis/chronic pelvic pain syndrome. J Urol. 2004, 172(3):839-845
[7] Miller LJ, Fischer KA, Goralnick SJ,et al.Interleukin-10 levels in seminal plasma: implications for chronic prostatitis-chronic pelvic pain syndrome.J Urol,2002,167(2 Pt 1):753-6
[8] Hochreiter WW, Nadler RB, Koch AE,et al. Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions. Urology. 2000,56(6): 1025-1029
[9] Motrich RD, Maccioni M,Molina R,et al. Presence of rNFgamma-secreting lymphocytes specific to prostate antigens in a group of chronic prostatitis patients. Clin Immunol,2005, 116(2): 149-57
[10] Jang TL, Schaeffer AJ. The role of cytokines in prostatitis. World J Urol,2003, 21(2):95-9
[11] Dinarello CA. Proinflammatory cytokines. Chest,2000,118(2):503-508
[12] Raeburn CD, Sheppard F, Barsness KA, et al.Cytokines for surgeons. Am J Surg,2002,183(3):268-273
[13] Opal SM, DePalo VA.Anti-inflammatory cytokines.Chest, 2000, 117 (4):1162-1172
[14] Raeburn CD, Sheppard F, Barsness KA,et al.Cytokines for surgeons. Am J Surg,2002,183(3):268-273
[15] Ozaki K, Leonard WJ.Cytokine and Cytokine Receptor Pleiotropy and Redundancy. The Journal of biological chemistry,2002,277(33): 29355-29358
[16] Lee CG, Homer RJ, Cohn L, et al. Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and -independent pathways. J Biol Chem, 2002; 277 (38):35466-74
[17] Riley DE, Krieger JN. X Chromosomal short tandem repeat polymorphisms near the phosphorglycerate kinase gene in men with chronic prostatitis. Biochim Biophys Acta, 2002 ,1586(1):99-107
[18] Riley DE, Krieger JN.Short tandem repeat polymorphism linkage to the androgen receptor gene in prostate carcinoma.Cancer, 2001 ,92(10):2603-2638
[19] Shoskes DA, Albakri Q, Thomas K,et al. Cytokine Polymorphisms in Men with Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Association with Diagnosis and Treatment Response. J Urol,2002 ,168(1):331-5
[20] Sachidanandam R, Weissman D, Schmidt SC, et al.A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature, 2001, 409(6822):928-933
[21 ]Turner DM, Williams DM,Sankaran D,et al.An investigation of polymorphism in the interleukin 10 gene promoter.Eur J Immuno Genet,1997,24(1):1-8
[22]Nadler RB, KochAE, CalhounEA, et al.IL-1beta and TNF-alpha in prostatic secretions are indicators in the eval uation of men with chronic prostatitis. J Urol,2000,164(1):214-218
[23] Koch AE,Kunkel SL,Harlow LA.Epithelial neutrophil acti vating peptide-78 :a novel chemotactic cytokine for neu trophils in arthritis. J Clin Invest, 1994, 94 (3):1012-1018
[24] Nishimum T,Abe H,Ito H, et al.IL-1ra versus IL-1 levels in prostatic fluid from prostatitis patients.Urol Int, 1998,60(2):92-96
[25] Witkin SS, Vardhana S, Yih M,et al. Polymorphism in intron 2 of the fetal interleukin-1 receptor antagonist genotype influences midtrimester amniotic fluid concentrations of interleukin-1beta and interleukin-1 receptor antagonist and pregnancy outcome. Am J Obstet Gynecol. 2003 Nov; 189(5): 1413-7
[26] Fang XM, Schroder S,Hoeft A,et al. Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis Crit Care Med,1999,27(7): 1330-1334
[27] van der Paardt M, Crusius JB, Garcia-Gonzalez MA, et al. Interleukin-lbeta and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis. Rheumatology (Oxford). 2002, 41(12): 1419-23
[28] Varner MW, Esplin MS. Current understanding of genetic factors in preterm birth. BJOG. 2005, 112 (Suppl 1) :28-31
[29] Kalish RB, Vardhana S, Gupta M,et al. Interleukin-1 receptor antagonist gene polymorphism and multifetal pregnancy Outcome. Am J Obstet Gynecol. 2003, 189(4):911-4
[30] Hall SK, Perregaux DG, Gabel CA,et al. Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein. Arthritis Rheum. 2004, 50(6):1976-83
[31] Ravindran JS, Owen P, Lagan A,et al. Interleukin lalpha, interleukin 1beta and interleukin 1 receptor gene polymorphisms in psoriatic arthritis.Rheumatology (Oxford), 2004, 43(1):22-6
[32] Karasneh J, Hajeer AH, Barrett J, Oilier WE, Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behcet's disease. Rheumatology (Oxford). 2003, 42(7):860-4
[33] Kawaguchi Y, Tochimoto A, Ichikawa N, Harigai M, Association of IL1A gene polymorphisms with susceptibility to and severity of systemic sclerosis in the Japanese population. Arthritis Rheum. 2003,48(1): 186-92
[34] Adjers K, Pessi T, Karjalainen J,et al. Epistatic effect of IL1A and IL4RA genes on the risk of atopy. J Allergy Clin Immunol. 2004,113(3):445-7
[35] Rad R, Prinz C, Neu B, et al. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J Infect Dis. 2003 Jul 15; 188(2):272-81
[36] 羊继平，齐隽，闵志廉，等。细胞因子基因多态性对肾移植急性排斥的影响。肾脏病与透析肾移植杂志，2005，14(1)：28-33
[37] Parkes M, Satsangi J, Jewell D. Contribution of the IL-2 and IL-10 genes to inflammatory bowel disease (IBD) susceptibility. Clin Exp Immunol, 1998,113 (1): 28-32
[38]Darrin EC, Steven CH, Barbara SD. Cytokine polymorphic ananlyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6. Transplantation, 2001, 72(4), 720-726
[39] Fishman D,Faulds G, Jeffery R,et al.The effect of novel polymorphisms in the interleukin-6(IL-6)gene on IL-6 transcription and plasma IL-6 levels,and an association with systemic-onset juvenile chronic arthritis.J Clin Invest,1998,102(7): 1369-76
[ 40 ] Mullighan C,Heatley S,Doherty K,et al.Non-HLA immunogenetic polymorphisms and the risk of complications after allogenetic hemopoietic stem cell transplantation. Transplantion, 2004,27 (4):587-596
[41 ] Schluter B, Raufhake C, Erren M, et al:Effect of the interleukin-6 promoter polymorphism (-174 G/C) on the incidence and outcome of sepsis. Crit Care Med, 2002, 30(1):32-37
[42] Akira S, Taga T, Kishimoto T.Interleukin-6 in biology and medicine. Adv Immunol,1993, 54:1-78
[43 ] Giri D, Ozen M, Ittmann M.Interleukin-6 is an autocrine growth factor in human prostate cancer. Am J Pathol ,2001,159(6): 2159-65
[44] Tan DF,Wu XX,Hou M. Interleukin-6 polymorphism is associated with more aggressive prostate cancer.The Journal of Urology.2005,174(2):753-756
[45] Morris SC, Madden KB, Adamovicz JJ,et al.Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J Immunol, 1994, 152(3): 1047-56
[46] Comabella M,Balashow K,Issazadeh S, et al. Hormones / cytokines / signaling:elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.J Clin Invest, 1998,102(4): 671-8
[47] Divino CM,Chen SH,Yang W,etal. Anti-tumor immunity induced by interleukin-12 gene therapy in a metastatic model of breast cancer is mediated by natural killer cells.Breast Cance Res Treat, 2000,60(2): 129-134
[48] Jamagin WR,Delman K,Kooby D,et al.Neo adjuvant interleukin-12 immuno genetherapy protects against cancer recurrence after liver resection in an animal model. AnnSurg,2000,23(5):762-771
[49] Hirota T, Suzuki Y, Hasegawa K,et al. Functional haplotypes of IL-12B are associated with childhood atopic asthma. J Allergy Clin Immunol. 2005, 116(4):789-95
[50] Ohyama H, Ogata K, Takeuchi K, Namisato M, Polymorphism of the 5' flanking region of the IL-12 receptor beta2 gene partially determines the clinical types of leprosy through impaired transcriptional activity. J Clin Pathol, 2005, 58(7):740-3
[51] Sanchez E, Morales S, Paco L,et al. Interleukin 12 (IL12B), interleukin 12 receptor (IL12RB1) and interleukin 23 (IL23A) gene polymorphism in systemic lupus erythematosus. Rheumatology (Oxford). 2005, 44(9): 1136-9
[52] Davoodi-Semiromi A, Yang JJ, She JX. IL-12p40 is associated with type 1 diabetes in Caucasian-American families. Diabetes. 2002, 51(7):2334-6.
[53] Choy ES,Panayigs.Cytokine pathways and joint inflammation in rheumatoid arthritis.N Engl Journal Med,2001,344(12):907-16
[54] Louis E, Franchimont D, Piron A, et al.Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans.Clin Exp Immunol,1998,113 (3):401-406
[55] Darrin EC, Steven C H, Barbara S D. Cytokine polymorphic ananlyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6. Transplantation, 2001, 72(4):720-726
[56] 田野，马威然，张玉海。细胞因子基因型多态性对肾移植效果的影响。中华医学杂志，2001，81(12)：719-721
[57] Lee H, Clark B, Gooi HC,et al. Influence of recipient and donor IL-lalpha, IL-4, and TNFalpha genotypes on the incidence of acute renal allograft rejection. J Clin Pathol. 2004, 57(1):101-103
[58] 汪明，李艳，张平安。湖北地区汉族人群TNF-β804C／A多态性研究。中国优生与遗传杂志，2004，12(1)：15-17
[59] Pociot F, Briant L, Jongeneel CV, et al.Association of tumor necrosis factor (TNF) and class Ⅱ major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: A possible link to insulin-dependent diabetes mellitus. Eur J Immunol, 1993, 23 (1): 224-231
[60] 田野，马威然，张玉海。 细胞因子基因型多态性对肾移植效果的影响。中华医学杂志，2001，81(12)：719-721
[61] Boehm U, Klamp T, Groot M, et al. Cellular responses to interferon-g.Annu Rev Immunol. 1997, 15:749-795
[62] Tambur AR., Ortegel J W, Ben-Ari Z,et al. Role of cytokine gene polymorphism in hepatitis C recurrence and allograft rejection among liver transplant recipients. Transplantation, 2001, 71(10) :1475-1480
[63] Scheneider A, Barmada MM, Slivka A, et al. Analysis of tumor necrosis factor-a, transforming growth factor-b Interleukin-10 and interferon-g polymorphisms in patients with alcoholic chronic pancreatitis. Alcohol.2004, 32:19-24
[64] Bendicho MT, Guedes JC,Silva, N N. Polymorphism of Cytokine Genes (TGF-b1, IFN-g, IL-6,IL-10, and TNF-a) in Patients With Chronic Pancreatitis.Pancreas, 2005, 30 (4) : 333-336
[65] Stassen NA, Leslie-Norfleet LA, Robertson AM, et al. Interferon -gamma gene polymorphisms and the development of sepsis in patients with trauma. Surgery. 2002, 132 (2): 289-292
[66] Davis EG, Eichenberger MR, Grant BS, et al: Microsatellite marker of interferongamma receptor 1 gene correlates with infection following major trauma. Surgery, 2000, 128(2):301-305
[67] van Roon JA, van Roy JL, Duits A,et al.Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4. Ann Rheum Dis, 1995, 54(10):836-840
[68] Sugiyama E, Kuroda A, Taki H, et al. Interleukin 10 cooperates with interleukin 4 to suppress inflammatory cytokine production by freshly prepared adherent rheumatoid synovial cells. J Rheumatol, 1995,22(11):2020-2026
[69] Dechanet J, Rissoan MC, Banchereau J,et al. Interleukin 4, but not interleukin 10, regulates the production of inflammation mediators by rheumatoid synoviocytes.Cytokine, 1995,7 (2): 176-183
[70] Bijlsma FJ,vanKuik J, Tilanus MG,et al.Donor interleukin-4 promoter gene polymorphism influences allograft rejection after heart transplantation. Journal of Heart & Lung Transplantation, 2002 , 21(3):340-6
[71] Kabesch M, Tzotcheva I, Carr D, A complete screening of the IL4 gene: novel polymorphisms and their association with asthma and IgE in childhood. J Allergy Clin Immunol. 2003, 112(5):893-8
[72] Basehore MJ, Howard TD, Lange LA,et al. A comprehensive evaluation of IL4 variants in ethnically diverse populations:association of total serum IgE levels and asthma in white subjects. J Allergy Clin Immunol. 2004, 114(1):80-7
[73] 刘东方，崔天盆，吴建民。白细胞介素4启动子区C33T多态性与血浆IgE水平关系。华中医学杂志，2003，27(1)：13-16
[74] 蒋玲，龚莹，江维岩，等。白细胞介素1α、4、6、TNF基因多态性与桥本甲状腺炎的关系。中华内分泌代谢杂志，2004，20(6)：528-530
[75] Hershey GK, Friedrich MF, Esswein LA,et al.The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor .N Engl J Med, 1997,337(24):1720-1725
[76] Rousser F, Carcia E,Defrance T, et al.Interleukin-10 is a potent growth and differentiation factor for activated human B lymphocytes.Proc Natl Acad Sci USA, 1992,89(5):1890-1893
[77] Zou WG, Wang DS, Lang MF, et al. Human interleukin 10 gene therapy decreases the severity and mortality of lethal pancreatitis in rats. 2002,103(1): 121-6
[78] Eskdale J, Kube D, Tesch H,et al. Mapping of the human IL-10 gene and further characterization of the 5_ flanking sequence. Immunogenetics 1997,46(2): 120-128
[79] Lin MT, Storer B, Martin PJ.Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med. 2003 , 349(23):2201-2210
[80] Barrett S, Collins M, Kenny C, Ryan E, Keane CO, Crowe J(2003) Polymorphisms in tumour necrosis factor-alpha, transforming growth factor-beta, interleukin-10, interleukin-6, interferon-gamma, and outcome of hepatitis C virus infection.J Med Virol 71 (2):212-218
[81] Hoffmann SC, Stanley EM, Darrin Cox E,et al. Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes. Transplantation. 2001, 72(8):1444-1450
[82] El-omar EM,Rabkin C S,Gammon AD,et al.Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroent -erology, 2003,124(5): 1193-1201
[83] Annells MF, Hart PH, Mullighan CG, et al.Interleukins-1, -4, -6, -10, tumor necrosis factor, transforming growth factor-beta, FAS, and mannose-binding protein C gene polymorphisms in Australian women: Risk of preterm birth.Am J Obstet Gynecol. 2004, 191 (6):2056-2067
[84] Eberhard Y, Burgos E, Gagliardi J, et al, Cytokine polymorphisms in patients with pemphigus.Arch Dermatol Res, 2005, 296(7): 309-313
[85] Havranek E,Howell WW, Fussell HM,et al.An interleukin-10 promoter polymorphism may influence tumor development in renal cell carcinoma. Journal of Urology.2005, 173 (3):709-712
[86] Mora-Garcia P, Sakamoto KM. Cell signaling defects and human disease.Mol Gen Med. 1999, 66 (3):143-171
[87] Arkwright PD, Chase JM, Babbage S, et al.Atopic dermatitis is associated with alow-producer transforming growth factor beta(1) cytokine genotype. J Allergy Clin Immunol,2001,108(2):281-284
[88] Yanina Eberhard, Elisa Burgos, Julio Gagliardi, et al.Cytokine polymorphisms in patients with pemphigus Arch Dermatol Res, 2005, 296: 309-313
[89] 徐群清，韦叶生，梁峰。广西瑶族与汉族人群TGF-β1基因启动子-509C／T多态性的研究。中国优生与遗传杂志，2005，13(7)：20-21
[90] 薛超，李幼姬，李彩霞，等。中国汉族人群TGF-β1基因-509C／T多态性及其IgA肾病的病例对照研究。中山大学学报(医学科学版)，2005，26(3)：260-263
[91] Gracie JA, Robertson SE McInnes IB.Interleukin-18.Journal of Leukocyte Biology. 2003,73(2):213-224
[92]Kruse S, Kuehr J, Moseler M.Polymorphisms in the IL 18 gene are associated with specific sensitization to common allergens and allergic rhinitis. J Allergy Clin Immunol. 2003,111(1):117-122
[93] Novak N,Kruse S,Potreck J,et al.Single nucleotide polymorphisms of the IL-18 gene are associated with atopic eczema.J Allergy Clin Immunol, 2005, 115 (4): 828-833
[94] Zimmermann N, Hershey GK, Foster PS, Chemokines in asthma: cooperative interaction between chemokines and IL-13. J Allergy Clin Immunol. 2003 , 111(2):227-242
[95] Zlotnik A, Yoshie O.Chemokines: a new classification system and their role in immunity. Immunity, 2000, 12 (2):121-127
[96] Jiang ZD, Okhuysen PC, Guo DC,et al. Genetic susceptibility to enteroaggregative Escherichia coli diarrhea:polymorphism in the interleukin-8 promotor region. J Infect Dis. 2003,188(4):506-11
[97] Heinzmann A, Ahlert I, Kurz T, Berner R, Association study suggests opposite effects of polymorphisms within IL8 on bronchial asthma and respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol,2004,114(3):671-6
[99] Ohyauchi M, Imatani A, Yonechi M,et al. The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population.Gut,2005,54(3):330-335
[100] Renzoni E, Lympany P, Sestini P,et al. Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis. Arthritis Rheum. 2000 ,43(7): 1633- 40
[101] Shahed AR, Shoskes DA.Correlation of [beta]-endorphin and prostaglandin E2 levels in prostatic fluid of patients with chronic prostatitis with diagnosis and treatment response.J Urol,2001,166 (5):1738-1741
[102]Rimarachin JA, Jacobson JA, Szabo P, et al.Regulation of cyclooxygenase-2 expression in aortic smooth muscle cells. Arterioscler Thromb,1994, 14(7):1021-1031
[103] Lacroix S, Rivest S.Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain. J Neurochem, 1998,70 (2): 452-466
[104] Brodie. Differential effects of Th1 and Th2 derived cytokines on NGF synthesis by mouse astrocytes.FEBS Lett,1996,394(2):117-120
[105] Miller LJ, Fischer KA, Goralnick SJ, et al.Nerve growth factor and chronic prostatitis chronic pelvic pain syndrome. Urology, 2002, 59(4): 603- 608
[106] Takagi N, Mihara M, Moriya Y, et al. Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis. Arthritis Rheum,1998,41(12):2117-2121
[107] Jiang Y, McCabe D, Aitchison R,et al. Relationship of Genant scoring method with Larsen scoring method in randomized, double- blind, placebo controlled trial of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Arthritis Rheum 2000 ,43 (5): 1001-9
[108] Hart PH, Hunt EK, Bonder CS,et al. Regulation of surface and soluble TNF receptor expression on human monocytes and synovial fluid macrophages by IL-4 and IL-10. J Immunol,1996,157(8):3672-3680
[ 109] Woods JM, Katschke KJ,Volin MV.IL-4 Adenoviral Gene Therapy Reduces Inflammation,Proinflammatory Cytokines, Vascularization, and Bony Destruction in Rat Adjuvant-Induced Arthritis. The Journal of Immunology, 2001, 166 (2): 1214-1222
[110] Charles P, Elliott MJ, Davis D .Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis. J Immunol, 1999 , 163(3):1521-1528 ; Vastag B. Prostate disease begs understanding. JAMA, 2001, 286(4): 406-408
[111] Baert FJ, D'Haens GR, Peeters M, et al. Tumor necrosis factor alpha antibody (infliximab) therapy profoundly downregulates the inflammation in Crohn's ileocolitis. Gastroenterology,1999,116(1):22-28
[112]Maini RN, Breedveld FC, Kalden JR, et al. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate.Arthritis Rheum. 2004 ,50(4): 1051-65
[113] Nickel JC, Pontari M, Moon T ,et al.A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. J Urol, 2003 ,169(4): 1401-5
[114] Dixon SC, Knopf KB, Figg WD.The Control of Prostate-Specific Antigen Expression and Gene Regulation by Pharmacological Agents. Pharmacol Rev, 2001, 53:73-91
[115] Downey J, Nickel JC, Pontari MA, et al. Randomized placebo controlled multi-center pilot study to evaluate the safety and efficacy of finasteride in the treatment of male chronic pelvic pain syndrome: category IIIA CPPS (chronic nonbacterial prostatitis). BJU Int, 2004 ,93(7):991-5
[116] Galley HF, Nelson SJ, Dubbels AM, et al.Effect of ciprofloxacin on the accumulation of interleukin-6, interleukin-8, and nitrite from a human endothelial cell model of sepsis. Crit Care Med, 1997, 25 (8) : 1392 - 1395
[117] D' Agostino P, Arcoleo F, Barbera C, et al.Tetracycline inhibits the nitric oxide synthase activity induced by endotoxin in cultured murine macrophages. Eur J Pharmacol, 1998, 346 (2-3) :283 - 290
[118] Bates S, Talbot M. Short course oral prednisolone therapy in chronic abacterial prostatitis and prostatodynia: case reports of three responders and one non-responder. Sex Transm Inf 398, 2000, 76 (5) :398-400
[119] Lundgren R, Holmquist B, Hesselvik M, et al.Treatment of prostatitis in the rat. The Prostate, 1984, 5 (3) :277 - 284
[120] Falzano L,Quaranta MG, Travaglione S,et al.Cytotoxic Necrotizing Factor 1 Enhances Reactive Oxygen Species-Dependent Transcription and Secretion of Proinflammatory Cytokines in Human Uroepithelial Cells.Infection And Immunity, 2003,71(7) :4178 - 4181
[121] Rugendorff EW, Weidner W, Ebeling L, et al. Results of treatment with pollen extracts (Cernilton N) in chronic prostatitis and prostatodynia. Br J Urol,1993,71 (4) :433-438
[2] Litwin MS,McNaughton-Collins M,Fowler FJ,et al.The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure.Chronic Prostatitis Collaborative Research Network.J Urol, 1999, 162(2):369-375
[3]Nickel JC,Downey J,Hunter D, et al.Prevalence of prostatitis-like symptoms in a population based study using the national institutes of health chronic prostatitis symptom index. J Urol, 2001,165(3): 842-845
[4] Hoffmann SC, Stanley EM, Cox ED, et al. Ethnicity greatly influences cytokine gene polymorphism distribution. American Journal of Transplantation. 2002, 2(6):560-567
[5] Miller LJ, Fischer KA, Goralnick SJ, Litt M, Burleson JA,Albertsen P, Kreutzer DL.Interleukin-10 levels in seminal plasma: implications for chronic prostatitis-chronic pelvic pain syndrome. J Urol , 2002, 167 (2 Pt 1)::753—756
[6] Hochreiter WW, Nadler RB, Koch AE,et al. Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions. Urology. 2000 ,56 (6): 1025-1029
[7]Krieger JN, Riley DE,Cheah PY, et al.Epidemiology of prostatitis: new evidence for a world-wide problem. World J Urol,2003,21(2): 70-74
[8] Ludwig M,Schroeder-Printzen I,Ludecke G,et al. Comparison of expressed prostatic secretions with urine after prostatic massage-a means to diagnose chronic prostatitis/inflammatory chronic pelvic pain syndrome. Urology ,2000, 55: 175-177
[9] Lobel B, Rodriguez A.Chronic prostatitis: what we know, what we do not know,and what we should do! World J Urol, 2003, 21 (2) : 57-63
[10] Cheah PY,Liong LM,Yuen KH,et al.Chronic prostatitis: Symptom survey with follow-up clinical evaluation.Urology, 2003, 61(1): 60-64
[11] Nickel JC, Downey JA, Nickel KR, Prostatitis-like symptoms: one year later. BJU Int. 2002 , 90(7): 678-681
[12] Roberts RO,Lieber MM,Rhodes T,etal.Prevalence of a physician- assigned diagnosis of prostatitis: the Olmsted county study of urinary symptoms and health status among men.Urology, 1998,51 (4) :578-584
[13] Harris MT, Feldberg RS, Lau KM,et al. Expression of proinflammatory genes during estrogen-induced inflammation of the rat prostate. Prostate, 2000, 44(1): 19-25
[14] Naber KG,Weidner W.Chronic prostatitis-an infectious disease? Journal of Antimicrobial Chemtherapy, 2000,46 (2):157-161
[15] Mandar R, Raukas E,Turk S,et al. Mycoplasmas in semen of chronic prostatitis patients. Scand J Urol Nephrol, 2005,39(6): 479-482
[16] Abdelatif OM,Chandler FW, McGuire JrBS. Chlamydia trachomatis in chronic abacterial prostatitis: demonstration by colorimetric in situ hybridization. Hum Pathol, 1991,22(1):41-44
[17] 曹伟，刘礼，童明华。淋球菌、支原体和沙眼衣原体在慢性前列腺炎中的感染分布及耐药性分析。湖南医科大学学报，2003，28(2)：177-179
[18] 蒋朝晖，杨金瑞．前列腺液白细胞计数在慢性前列腺炎诊断中的作用。中华泌尿外科杂志，2002，23(1)：32-34
[19] Schaeffer AJ,Knauss JS,Landis R, et al.Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis:the national institutes of health chronic prostatitis cohort study.J Urol,2002,168 (3):1048-1053
[20] Nickel JC,Downey J,Johnston B,et al.Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronie pelvic pain syndrome:a prospective multicenter clinical trial.J Urol,2001,165 (5):1539-1544
[21] Batstone GR, Doble A, Batstone D. Chronic prostatitis. Curr Opin Urol, 2003, 13(1):23-29
[22] Karlovsky ME,Pontari MA:Theories of prostatitis etiology.Curr Urol Rep.2002,3(4):307-312
[23] Jang TL,Schaeffer AJ.The role of cytokines in prostatitis.World J Urol,2003, 21 (1): 95-99
[24] Riley DE, Krieger JN. X Chromosomal short tandem repeat polymorphisms near the phosphorglycerate kinase gene in men with chronic prostatitis. Biochim Biophys Acta,2002,1586(1):99-107
[25] Shoskes DA, Albakri Q, Thomas K,et al.Cytokine polymorphisms in men withchronic prostatitis/chronic pelvic pain syndrome: association with diagnosis and treatment response. J Urol,2002,168(1):331-5
[26] SNP的原理和临床应用。朱平。临床分子遗传学。北京，北京医科大学出版社，2002年4月第一版：65-71
[27] 郭义峰 谭建明 李荣宇，等。寡核苷酸芯片在细胞因子及其受体单核苷酸多态性检测中的应用。中华医学杂志，2005，85(25)：1757-1761
[28] Orhan I, Onur R, Ilhan N,et al. Seminal plasma cytokine levels in the diagnosis of chronic pelvic pain syndrome. Int J Urol,2001,8(9):495-9
[29] 杨进益，叶林，姜洪波，等。 慢性前列腺炎患者前列腺液IL-1B和TNF-A的检测及意义．中华男科学杂志，2004，10(6)：449-454
[30] 段志国，杨为民。慢性前列腺炎患者前列腺液中IL-2、IL-8及IL-10水平分析．中华男科学，2005，11(3)：201-203
[31] Lin MY, Albertson TE. Genomic polymorphisms in sepsis. Crit Care Med, 2004, 32 (2):569-579
[32] Louis E, Franchimont D, Piron A, et al:Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans.Clin Exp Immunol,1998, 113 (3):401-406
[33] Mira JP, Cariou A,Grall F, et al. Association of TNF2a, TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA,1999,282 (6): 561-568
[34] Mullighan C,Heatley S,Doherty K,et al.Non-HLA immunogenetic polymorphisms and the risk of complications after allogenetic hemopoietic stem cell transplantation. Transplantion, 2004, 27(4):587-596
[35] Lee H, Clark B, Gooi HC,et al. Influence of recipient and donor IL-lalpha, IL-4, and TNF alpha genotypes on the incidence of acute renal allograft rejection. J Clin Pathol. 2004,57(1): 101-103
[36] Macones G,Parry S,Elkousy, etal.A polymorphism in the promoter region of TNF and bacterial vaginesis:preliminary evidence of gene environment interaction in the etiology of spontaneous preterm birth.Am J Obestect Gynecol, 2004, 160 (6): 1504-1508
[37] Krieger JN, Riley DE, Cheah PK, et al.Epidemiology of prostatitis: new evidence for a world-wide problem.World J Urol,2003,21 (2): 70-74
[38] Naber KG;Weidner W.Chronic prostatitis-an infectious disease? .Journal of Antimicrobial Chemtherapy, 2000, 46 (2):157-161
[39] Motrich RD, Maccioni M,Molina R, et al. Presence of INFgamma-secreting lymphocytes specific to prostate antigens in a group of chronic prostatitis patients. Clin Immunol, 2005, 116(2): 149-57
[40] 羊继平，齐隽，闵志廉，等。肾移植受者细胞因子基因多态性与术后发生感染的关系。中华器官移植杂志，2005，26(2)：97-99
[41] 江，马文波，章锦才，等。IL-6基因多态性与汉族人群慢性牙周炎敏感性关系的研究．广东牙病防治。2003,11(2)：89-92
[42] Fishman D,Faulds G.Jeffery R,et al.The effect of novel polymorphisms in the interleukin-6(IL-6)gene on IL-6 transcription and plasma IL-6 levels,and an association with systemic-onset juvenile chronic arthritis,J Clin Invest, 1998,102(7):1369-1376
[43] Jones KG, Brull DJ, Brown LC, et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation,2001, 103 (18):2260-2265
[44] Rousser F, Carcia E,Defrance T, et al.Interleukin-10 is a potent growth and differentiation factor for activated human B lymphocytes.Proc Natl Acad Sci USA,1992,89 (5) :1890-1893
[45] Eskdale J, Kube D, Tesch H,et al. Mapping of the human IL10 gene and further characterization of the 5_ flanking sequence. Immunogenetics, 1997,46 (2):120-128
[46] Hoffmann SC,Stanley EM,Cox ED,et al.Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28 stimulated peripheral blood lymphocytes.Transplantation, 2001,72 (8): 1444-1450
[47] 王娟，刘岩雪，倪虹，等。白细胞介素-10启动子-872位点多态性在中国汉 族人群高频率发生。南开大学学报(自然科学版)，2004，37(3)：80-82
[48] Turner DM, Williams DM, Sankaran D, et al. An investigation of polymorphism in the interleukin -10 gene promoter. Eur J Immunogenet,1997, 24 (1):1-8
[49] Lin MY, Storer B, Martin PJ et al. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation.N Engl J Med, 2003,349(23):2201-10
[50] Mok CC,Lanchbury JS,Chan DW, et al. Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum, 1998, 41(6):1090-1095
[51] Crawley E,Kay R, Silliboume J, et al. Polymorphic haplotypes of the interleukin- 10 5' flanking region determine variable interleukin- 10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. ArthritisRheum,1999, 42(6): 1101-1108
[52] 张嘉琳，陈虹，胡良平，等。细胞介素4和10基因多态性与儿童哮喘的相关性及对细胞因子表达的影响。中华医学杂志，2002，82(2)：114-118
[53] Pongtari MA,Ruggieri MR.Mechanisms in prostatitis/chronic pelvic pain syndrome. J Urol. 2004, 172(3):839-845
[54] Hochreiter WW, Nadler RB, Koch AE,et al. Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions. Urology. 2000,56(6): 1025-1029
[55] Sugiyama E, Kuroda A, Taki H, et al. Interleukin 10 cooperates with interleukin 4 to suppress inflammatory cytokine production by freshly prepared adherent rheumatoid synovial cells. J Rheumatol,1995,22 (11): 2020-6
[56] Bijlsma FJ,vanKuik J, Tilanus MG;et al.Donor interleukin-4 promoter gene polymorphism influences allograft rejection after heart transplantation. Journal of Heart & Lung Transplantation, 2002, 21(3):340-6
[57] Maccioni M,Rivero VE,Riera CM.prostaein(or rat prostatic steroid binding protein) is a major autoantigen in experimental autoimmune prostatitis.Clinical Experimental Immunology, 1998,112(2): 159-165
[58] Seethalakshmi L,Bala RS,Malhotra RK,et al. 17 beta-Estradiol Induced Prostatitis in the Rat is an Autoimmune Disease.The Journal of Urology,1996, 156 (5):1838-1842
[59] 蒋玲，龚莹，江维岩，等。白细胞介素1α、4、6、TNF基因多态性与桥本甲状腺炎的关系。中华内分泌代谢杂志，2004，20(6)：528-530
[60] Hershey GK, Friedrich MF, Esswein LA,et al.The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor .N Engl J Med, 1997,337(24): 1720
[61] 羊继平，齐隽，闵志廉，等。细胞因子基因多态性对肾移植急性排斥的影响。肾脏病与透析肾移植杂志，2005，14(1)：28-33
[62] Krieger JN , Riley DE. Chronic prostatitis: charlottesville to Seattle. J Urol,2004, 172(6 Pt 2): 2557-2560
[63] Nickel JC, Downey J, Ardern D,et al. Failure of a monotherapy strategy for difficult chronic prostatitis/chronic pelvic pain syndrome. J Urol. 2004,172(2):551-4
[64] Charles P, Elliott M J, Davis D .Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis. J Immunol, 1999, 163(3): 1521-1528; Vastag B. Prostate disease begs understanding. JAMA, 2001, 286(4):406-408
[65] Jiang Y, McCabe D, Aitchison R,et al. Relationship of Genant scoring method with Larsen scoring method in randomized, double- blind, placebo controlled trial of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Arthritis Rheum 1998,41(Suppl):S50
[66] Woods JM, Katschke KJ,Volin MV.IL-4 Adenoviral Gene Therapy Reduces Inflammation,Proinflammatory Cytokines, Vascularization, and Bony Destruction in Rat Adjuvant-Induced Arthritis. The Journal of Immunology,2001,166(2): 1214-1222
[67] Maini RN, Breedveld FC, Kalden JR, et al. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate.Arthritis Rheum.2004,50(4): 1051-65
[1] Krieger JN, Riley DE,Cheah PY, et al.Epidemiology of prostatitis: new evidence for a world-wide problem.World J Urol,2003,21(2): 70-74
[2] Nickel JC,Downey J,Hunter D,et al.Prevalence of prostatitis-like symptoms in a population based study using the National institude of Health chronic prostatitis symptom index.J Urol,2001,165(3):842-845
[3 ]Batstone GR, Doble A, Batstone D. Chronic prostatitis. Curr Opin Urol, 2003, 13(1):23-9
[4] Moon TD, Hagen L, Heisey DM .Urinary symptomatology in younger men. Urology, 1997, 50(5):700-703
[4] John H,Barghorn A,Funke GNoinflammatory chronic pelvic pain synd-rome:immunological study in blood,ejaculate and prostate tissue.Eur Urol,2001,39(1):72-78
[6] Pongtari MA,Ruggieri MR.Mechanisms in prostatitis/chronic pelvic pain syndrome. J Urol. 2004, 172(3):839-845
[7] Miller LJ, Fischer KA, Goralnick SJ,et al.Interleukin-10 levels in seminal plasma: implications for chronic prostatitis-chronic pelvic pain syndrome.J Urol,2002,167(2 Pt 1):753-6
[8] Hochreiter WW, Nadler RB, Koch AE,et al. Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions. Urology. 2000,56(6): 1025-1029
[9] Motrich RD, Maccioni M,Molina R,et al. Presence of rNFgamma-secreting lymphocytes specific to prostate antigens in a group of chronic prostatitis patients. Clin Immunol,2005, 116(2): 149-57
[10] Jang TL, Schaeffer AJ. The role of cytokines in prostatitis. World J Urol,2003, 21(2):95-9
[11] Dinarello CA. Proinflammatory cytokines. Chest,2000,118(2):503-508
[12] Raeburn CD, Sheppard F, Barsness KA, et al.Cytokines for surgeons. Am J Surg,2002,183(3):268-273
[13] Opal SM, DePalo VA.Anti-inflammatory cytokines.Chest, 2000, 117 (4):1162-1172
[14] Raeburn CD, Sheppard F, Barsness KA,et al.Cytokines for surgeons. Am J Surg,2002,183(3):268-273
[15] Ozaki K, Leonard WJ.Cytokine and Cytokine Receptor Pleiotropy and Redundancy. The Journal of biological chemistry,2002,277(33): 29355-29358
[16] Lee CG, Homer RJ, Cohn L, et al. Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and -independent pathways. J Biol Chem, 2002; 277 (38):35466-74
[17] Riley DE, Krieger JN. X Chromosomal short tandem repeat polymorphisms near the phosphorglycerate kinase gene in men with chronic prostatitis. Biochim Biophys Acta, 2002 ,1586(1):99-107
[18] Riley DE, Krieger JN.Short tandem repeat polymorphism linkage to the androgen receptor gene in prostate carcinoma.Cancer, 2001 ,92(10):2603-2638
[19] Shoskes DA, Albakri Q, Thomas K,et al. Cytokine Polymorphisms in Men with Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Association with Diagnosis and Treatment Response. J Urol,2002 ,168(1):331-5
[20] Sachidanandam R, Weissman D, Schmidt SC, et al.A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature, 2001, 409(6822):928-933
[21 ]Turner DM, Williams DM,Sankaran D,et al.An investigation of polymorphism in the interleukin 10 gene promoter.Eur J Immuno Genet,1997,24(1):1-8
[22]Nadler RB, KochAE, CalhounEA, et al.IL-1beta and TNF-alpha in prostatic secretions are indicators in the eval uation of men with chronic prostatitis. J Urol,2000,164(1):214-218
[23] Koch AE,Kunkel SL,Harlow LA.Epithelial neutrophil acti vating peptide-78 :a novel chemotactic cytokine for neu trophils in arthritis. J Clin Invest, 1994, 94 (3):1012-1018
[24] Nishimum T,Abe H,Ito H, et al.IL-1ra versus IL-1 levels in prostatic fluid from prostatitis patients.Urol Int, 1998,60(2):92-96
[25] Witkin SS, Vardhana S, Yih M,et al. Polymorphism in intron 2 of the fetal interleukin-1 receptor antagonist genotype influences midtrimester amniotic fluid concentrations of interleukin-1beta and interleukin-1 receptor antagonist and pregnancy outcome. Am J Obstet Gynecol. 2003 Nov; 189(5): 1413-7
[26] Fang XM, Schroder S,Hoeft A,et al. Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis Crit Care Med,1999,27(7): 1330-1334
[27] van der Paardt M, Crusius JB, Garcia-Gonzalez MA, et al. Interleukin-lbeta and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis. Rheumatology (Oxford). 2002, 41(12): 1419-23
[28] Varner MW, Esplin MS. Current understanding of genetic factors in preterm birth. BJOG. 2005, 112 (Suppl 1) :28-31
[29] Kalish RB, Vardhana S, Gupta M,et al. Interleukin-1 receptor antagonist gene polymorphism and multifetal pregnancy Outcome. Am J Obstet Gynecol. 2003, 189(4):911-4
[30] Hall SK, Perregaux DG, Gabel CA,et al. Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein. Arthritis Rheum. 2004, 50(6):1976-83
[31] Ravindran JS, Owen P, Lagan A,et al. Interleukin lalpha, interleukin 1beta and interleukin 1 receptor gene polymorphisms in psoriatic arthritis.Rheumatology (Oxford), 2004, 43(1):22-6
[32] Karasneh J, Hajeer AH, Barrett J, Oilier WE, Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behcet's disease. Rheumatology (Oxford). 2003, 42(7):860-4
[33] Kawaguchi Y, Tochimoto A, Ichikawa N, Harigai M, Association of IL1A gene polymorphisms with susceptibility to and severity of systemic sclerosis in the Japanese population. Arthritis Rheum. 2003,48(1): 186-92
[34] Adjers K, Pessi T, Karjalainen J,et al. Epistatic effect of IL1A and IL4RA genes on the risk of atopy. J Allergy Clin Immunol. 2004,113(3):445-7
[35] Rad R, Prinz C, Neu B, et al. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J Infect Dis. 2003 Jul 15; 188(2):272-81
[36] 羊继平，齐隽，闵志廉，等。细胞因子基因多态性对肾移植急性排斥的影响。肾脏病与透析肾移植杂志，2005，14(1)：28-33
[37] Parkes M, Satsangi J, Jewell D. Contribution of the IL-2 and IL-10 genes to inflammatory bowel disease (IBD) susceptibility. Clin Exp Immunol, 1998,113 (1): 28-32
[38]Darrin EC, Steven CH, Barbara SD. Cytokine polymorphic ananlyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6. Transplantation, 2001, 72(4), 720-726
[39] Fishman D,Faulds G, Jeffery R,et al.The effect of novel polymorphisms in the interleukin-6(IL-6)gene on IL-6 transcription and plasma IL-6 levels,and an association with systemic-onset juvenile chronic arthritis.J Clin Invest,1998,102(7): 1369-76
[ 40 ] Mullighan C,Heatley S,Doherty K,et al.Non-HLA immunogenetic polymorphisms and the risk of complications after allogenetic hemopoietic stem cell transplantation. Transplantion, 2004,27 (4):587-596
[41 ] Schluter B, Raufhake C, Erren M, et al:Effect of the interleukin-6 promoter polymorphism (-174 G/C) on the incidence and outcome of sepsis. Crit Care Med, 2002, 30(1):32-37
[42] Akira S, Taga T, Kishimoto T.Interleukin-6 in biology and medicine. Adv Immunol,1993, 54:1-78
[43 ] Giri D, Ozen M, Ittmann M.Interleukin-6 is an autocrine growth factor in human prostate cancer. Am J Pathol ,2001,159(6): 2159-65
[44] Tan DF,Wu XX,Hou M. Interleukin-6 polymorphism is associated with more aggressive prostate cancer.The Journal of Urology.2005,174(2):753-756
[45] Morris SC, Madden KB, Adamovicz JJ,et al.Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J Immunol, 1994, 152(3): 1047-56
[46] Comabella M,Balashow K,Issazadeh S, et al. Hormones / cytokines / signaling:elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.J Clin Invest, 1998,102(4): 671-8
[47] Divino CM,Chen SH,Yang W,etal. Anti-tumor immunity induced by interleukin-12 gene therapy in a metastatic model of breast cancer is mediated by natural killer cells.Breast Cance Res Treat, 2000,60(2): 129-134
[48] Jamagin WR,Delman K,Kooby D,et al.Neo adjuvant interleukin-12 immuno genetherapy protects against cancer recurrence after liver resection in an animal model. AnnSurg,2000,23(5):762-771
[49] Hirota T, Suzuki Y, Hasegawa K,et al. Functional haplotypes of IL-12B are associated with childhood atopic asthma. J Allergy Clin Immunol. 2005, 116(4):789-95
[50] Ohyama H, Ogata K, Takeuchi K, Namisato M, Polymorphism of the 5' flanking region of the IL-12 receptor beta2 gene partially determines the clinical types of leprosy through impaired transcriptional activity. J Clin Pathol, 2005, 58(7):740-3
[51] Sanchez E, Morales S, Paco L,et al. Interleukin 12 (IL12B), interleukin 12 receptor (IL12RB1) and interleukin 23 (IL23A) gene polymorphism in systemic lupus erythematosus. Rheumatology (Oxford). 2005, 44(9): 1136-9
[52] Davoodi-Semiromi A, Yang JJ, She JX. IL-12p40 is associated with type 1 diabetes in Caucasian-American families. Diabetes. 2002, 51(7):2334-6.
[53] Choy ES,Panayigs.Cytokine pathways and joint inflammation in rheumatoid arthritis.N Engl Journal Med,2001,344(12):907-16
[54] Louis E, Franchimont D, Piron A, et al.Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans.Clin Exp Immunol,1998,113 (3):401-406
[55] Darrin EC, Steven C H, Barbara S D. Cytokine polymorphic ananlyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6. Transplantation, 2001, 72(4):720-726
[56] 田野，马威然，张玉海。细胞因子基因型多态性对肾移植效果的影响。中华医学杂志，2001，81(12)：719-721
[57] Lee H, Clark B, Gooi HC,et al. Influence of recipient and donor IL-lalpha, IL-4, and TNFalpha genotypes on the incidence of acute renal allograft rejection. J Clin Pathol. 2004, 57(1):101-103
[58] 汪明，李艳，张平安。湖北地区汉族人群TNF-β804C／A多态性研究。中国优生与遗传杂志，2004，12(1)：15-17
[59] Pociot F, Briant L, Jongeneel CV, et al.Association of tumor necrosis factor (TNF) and class Ⅱ major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: A possible link to insulin-dependent diabetes mellitus. Eur J Immunol, 1993, 23 (1): 224-231
[60] 田野，马威然，张玉海。 细胞因子基因型多态性对肾移植效果的影响。中华医学杂志，2001，81(12)：719-721
[61] Boehm U, Klamp T, Groot M, et al. Cellular responses to interferon-g.Annu Rev Immunol. 1997, 15:749-795
[62] Tambur AR., Ortegel J W, Ben-Ari Z,et al. Role of cytokine gene polymorphism in hepatitis C recurrence and allograft rejection among liver transplant recipients. Transplantation, 2001, 71(10) :1475-1480
[63] Scheneider A, Barmada MM, Slivka A, et al. Analysis of tumor necrosis factor-a, transforming growth factor-b Interleukin-10 and interferon-g polymorphisms in patients with alcoholic chronic pancreatitis. Alcohol.2004, 32:19-24
[64] Bendicho MT, Guedes JC,Silva, N N. Polymorphism of Cytokine Genes (TGF-b1, IFN-g, IL-6,IL-10, and TNF-a) in Patients With Chronic Pancreatitis.Pancreas, 2005, 30 (4) : 333-336
[65] Stassen NA, Leslie-Norfleet LA, Robertson AM, et al. Interferon -gamma gene polymorphisms and the development of sepsis in patients with trauma. Surgery. 2002, 132 (2): 289-292
[66] Davis EG, Eichenberger MR, Grant BS, et al: Microsatellite marker of interferongamma receptor 1 gene correlates with infection following major trauma. Surgery, 2000, 128(2):301-305
[67] van Roon JA, van Roy JL, Duits A,et al.Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4. Ann Rheum Dis, 1995, 54(10):836-840
[68] Sugiyama E, Kuroda A, Taki H, et al. Interleukin 10 cooperates with interleukin 4 to suppress inflammatory cytokine production by freshly prepared adherent rheumatoid synovial cells. J Rheumatol, 1995,22(11):2020-2026
[69] Dechanet J, Rissoan MC, Banchereau J,et al. Interleukin 4, but not interleukin 10, regulates the production of inflammation mediators by rheumatoid synoviocytes.Cytokine, 1995,7 (2): 176-183
[70] Bijlsma FJ,vanKuik J, Tilanus MG,et al.Donor interleukin-4 promoter gene polymorphism influences allograft rejection after heart transplantation. Journal of Heart & Lung Transplantation, 2002 , 21(3):340-6
[71] Kabesch M, Tzotcheva I, Carr D, A complete screening of the IL4 gene: novel polymorphisms and their association with asthma and IgE in childhood. J Allergy Clin Immunol. 2003, 112(5):893-8
[72] Basehore MJ, Howard TD, Lange LA,et al. A comprehensive evaluation of IL4 variants in ethnically diverse populations:association of total serum IgE levels and asthma in white subjects. J Allergy Clin Immunol. 2004, 114(1):80-7
[73] 刘东方，崔天盆，吴建民。白细胞介素4启动子区C33T多态性与血浆IgE水平关系。华中医学杂志，2003，27(1)：13-16
[74] 蒋玲，龚莹，江维岩，等。白细胞介素1α、4、6、TNF基因多态性与桥本甲状腺炎的关系。中华内分泌代谢杂志，2004，20(6)：528-530
[75] Hershey GK, Friedrich MF, Esswein LA,et al.The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor .N Engl J Med, 1997,337(24):1720-1725
[76] Rousser F, Carcia E,Defrance T, et al.Interleukin-10 is a potent growth and differentiation factor for activated human B lymphocytes.Proc Natl Acad Sci USA, 1992,89(5):1890-1893
[77] Zou WG, Wang DS, Lang MF, et al. Human interleukin 10 gene therapy decreases the severity and mortality of lethal pancreatitis in rats. 2002,103(1): 121-6
[78] Eskdale J, Kube D, Tesch H,et al. Mapping of the human IL-10 gene and further characterization of the 5_ flanking sequence. Immunogenetics 1997,46(2): 120-128
[79] Lin MT, Storer B, Martin PJ.Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med. 2003 , 349(23):2201-2210
[80] Barrett S, Collins M, Kenny C, Ryan E, Keane CO, Crowe J(2003) Polymorphisms in tumour necrosis factor-alpha, transforming growth factor-beta, interleukin-10, interleukin-6, interferon-gamma, and outcome of hepatitis C virus infection.J Med Virol 71 (2):212-218
[81] Hoffmann SC, Stanley EM, Darrin Cox E,et al. Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes. Transplantation. 2001, 72(8):1444-1450
[82] El-omar EM,Rabkin C S,Gammon AD,et al.Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroent -erology, 2003,124(5): 1193-1201
[83] Annells MF, Hart PH, Mullighan CG, et al.Interleukins-1, -4, -6, -10, tumor necrosis factor, transforming growth factor-beta, FAS, and mannose-binding protein C gene polymorphisms in Australian women: Risk of preterm birth.Am J Obstet Gynecol. 2004, 191 (6):2056-2067
[84] Eberhard Y, Burgos E, Gagliardi J, et al, Cytokine polymorphisms in patients with pemphigus.Arch Dermatol Res, 2005, 296(7): 309-313
[85] Havranek E,Howell WW, Fussell HM,et al.An interleukin-10 promoter polymorphism may influence tumor development in renal cell carcinoma. Journal of Urology.2005, 173 (3):709-712
[86] Mora-Garcia P, Sakamoto KM. Cell signaling defects and human disease.Mol Gen Med. 1999, 66 (3):143-171
[87] Arkwright PD, Chase JM, Babbage S, et al.Atopic dermatitis is associated with alow-producer transforming growth factor beta(1) cytokine genotype. J Allergy Clin Immunol,2001,108(2):281-284
[88] Yanina Eberhard, Elisa Burgos, Julio Gagliardi, et al.Cytokine polymorphisms in patients with pemphigus Arch Dermatol Res, 2005, 296: 309-313
[89] 徐群清，韦叶生，梁峰。广西瑶族与汉族人群TGF-β1基因启动子-509C／T多态性的研究。中国优生与遗传杂志，2005，13(7)：20-21
[90] 薛超，李幼姬，李彩霞，等。中国汉族人群TGF-β1基因-509C／T多态性及其IgA肾病的病例对照研究。中山大学学报(医学科学版)，2005，26(3)：260-263
[91] Gracie JA, Robertson SE McInnes IB.Interleukin-18.Journal of Leukocyte Biology. 2003,73(2):213-224
[92]Kruse S, Kuehr J, Moseler M.Polymorphisms in the IL 18 gene are associated with specific sensitization to common allergens and allergic rhinitis. J Allergy Clin Immunol. 2003,111(1):117-122
[93] Novak N,Kruse S,Potreck J,et al.Single nucleotide polymorphisms of the IL-18 gene are associated with atopic eczema.J Allergy Clin Immunol, 2005, 115 (4): 828-833
[94] Zimmermann N, Hershey GK, Foster PS, Chemokines in asthma: cooperative interaction between chemokines and IL-13. J Allergy Clin Immunol. 2003 , 111(2):227-242
[95] Zlotnik A, Yoshie O.Chemokines: a new classification system and their role in immunity. Immunity, 2000, 12 (2):121-127
[96] Jiang ZD, Okhuysen PC, Guo DC,et al. Genetic susceptibility to enteroaggregative Escherichia coli diarrhea:polymorphism in the interleukin-8 promotor region. J Infect Dis. 2003,188(4):506-11
[97] Heinzmann A, Ahlert I, Kurz T, Berner R, Association study suggests opposite effects of polymorphisms within IL8 on bronchial asthma and respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol,2004,114(3):671-6
[99] Ohyauchi M, Imatani A, Yonechi M,et al. The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population.Gut,2005,54(3):330-335
[100] Renzoni E, Lympany P, Sestini P,et al. Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis. Arthritis Rheum. 2000 ,43(7): 1633- 40
[101] Shahed AR, Shoskes DA.Correlation of [beta]-endorphin and prostaglandin E2 levels in prostatic fluid of patients with chronic prostatitis with diagnosis and treatment response.J Urol,2001,166 (5):1738-1741
[102]Rimarachin JA, Jacobson JA, Szabo P, et al.Regulation of cyclooxygenase-2 expression in aortic smooth muscle cells. Arterioscler Thromb,1994, 14(7):1021-1031
[103] Lacroix S, Rivest S.Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain. J Neurochem, 1998,70 (2): 452-466
[104] Brodie. Differential effects of Th1 and Th2 derived cytokines on NGF synthesis by mouse astrocytes.FEBS Lett,1996,394(2):117-120
[105] Miller LJ, Fischer KA, Goralnick SJ, et al.Nerve growth factor and chronic prostatitis chronic pelvic pain syndrome. Urology, 2002, 59(4): 603- 608
[106] Takagi N, Mihara M, Moriya Y, et al. Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis. Arthritis Rheum,1998,41(12):2117-2121
[107] Jiang Y, McCabe D, Aitchison R,et al. Relationship of Genant scoring method with Larsen scoring method in randomized, double- blind, placebo controlled trial of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Arthritis Rheum 2000 ,43 (5): 1001-9
[108] Hart PH, Hunt EK, Bonder CS,et al. Regulation of surface and soluble TNF receptor expression on human monocytes and synovial fluid macrophages by IL-4 and IL-10. J Immunol,1996,157(8):3672-3680
[ 109] Woods JM, Katschke KJ,Volin MV.IL-4 Adenoviral Gene Therapy Reduces Inflammation,Proinflammatory Cytokines, Vascularization, and Bony Destruction in Rat Adjuvant-Induced Arthritis. The Journal of Immunology, 2001, 166 (2): 1214-1222
[110] Charles P, Elliott MJ, Davis D .Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis. J Immunol, 1999 , 163(3):1521-1528 ; Vastag B. Prostate disease begs understanding. JAMA, 2001, 286(4): 406-408
[111] Baert FJ, D'Haens GR, Peeters M, et al. Tumor necrosis factor alpha antibody (infliximab) therapy profoundly downregulates the inflammation in Crohn's ileocolitis. Gastroenterology,1999,116(1):22-28
[112]Maini RN, Breedveld FC, Kalden JR, et al. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate.Arthritis Rheum. 2004 ,50(4): 1051-65
[113] Nickel JC, Pontari M, Moon T ,et al.A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. J Urol, 2003 ,169(4): 1401-5
[114] Dixon SC, Knopf KB, Figg WD.The Control of Prostate-Specific Antigen Expression and Gene Regulation by Pharmacological Agents. Pharmacol Rev, 2001, 53:73-91
[115] Downey J, Nickel JC, Pontari MA, et al. Randomized placebo controlled multi-center pilot study to evaluate the safety and efficacy of finasteride in the treatment of male chronic pelvic pain syndrome: category IIIA CPPS (chronic nonbacterial prostatitis). BJU Int, 2004 ,93(7):991-5
[116] Galley HF, Nelson SJ, Dubbels AM, et al.Effect of ciprofloxacin on the accumulation of interleukin-6, interleukin-8, and nitrite from a human endothelial cell model of sepsis. Crit Care Med, 1997, 25 (8) : 1392 - 1395
[117] D' Agostino P, Arcoleo F, Barbera C, et al.Tetracycline inhibits the nitric oxide synthase activity induced by endotoxin in cultured murine macrophages. Eur J Pharmacol, 1998, 346 (2-3) :283 - 290
[118] Bates S, Talbot M. Short course oral prednisolone therapy in chronic abacterial prostatitis and prostatodynia: case reports of three responders and one non-responder. Sex Transm Inf 398, 2000, 76 (5) :398-400
[119] Lundgren R, Holmquist B, Hesselvik M, et al.Treatment of prostatitis in the rat. The Prostate, 1984, 5 (3) :277 - 284
[120] Falzano L,Quaranta MG, Travaglione S,et al.Cytotoxic Necrotizing Factor 1 Enhances Reactive Oxygen Species-Dependent Transcription and Secretion of Proinflammatory Cytokines in Human Uroepithelial Cells.Infection And Immunity, 2003,71(7) :4178 - 4181
[121] Rugendorff EW, Weidner W, Ebeling L, et al. Results of treatment with pollen extracts (Cernilton N) in chronic prostatitis and prostatodynia. Br J Urol,1993,71 (4) :433-438